398 / 1498
PR ≥ 2.5cm/PET-
PR ≥ 2.5cm/PET+
CR/CRu (no PET)
Time to progression
0.0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1.0
0
12
24
36
48
60
540
PET-
517
449
338
224
118
188
PET+
166
139
97
58
35
854
CR/CRu
811
690
482
303
155
Pts. at Risk
Months from randomization
HD15-PET trial
Impact of response and PET status (TTP)
NPV@12m:
94%
(95% CI: 92% to 96%)